Results 201 to 210 of about 23,434,422 (312)
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Multidisciplinary damage control management of life-threatening carotid blowout syndrome. [PDF]
Rezende-Neto JB +7 more
europepmc +1 more source
SYSTEMIC ANTIOXIDANTS IN MANAGEMENT OF ORAL SUBMUCOUS FIBROSIS: A SYSTEMATIC REVIEW OF RANDOMISED CONTROL TRIALS AND META–ANALYSIS. [PDF]
Dr.KondajjiRamchandra. Vijayalakshmi. +2 more
openalex +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Unintended consequences and the paradox of control: Management of emerging pathogens with age-specific virulence. [PDF]
Carran S, Ferrari M, Reluga T.
europepmc +1 more source
ABSTRACT Aims This study aimed to explore the relationship between stress‐induced hyperglycemia (SIH) and in‐hospital medical complications in patients with acute stroke. Methods We enrolled 865,765 patients with acute stroke from the Chinese Stroke Center Alliance cohort.
Xintong Song +6 more
wiley +1 more source
Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction. [PDF]
von Haehling S +5 more
europepmc +1 more source

